Skip to main content
. 2013 Sep 29;4(11):1963–1975. doi: 10.18632/oncotarget.1419

Figure 2. BAX knockout does not affect sensitivity to 17-AAG in HCT116 human colon cancer cells as measured by SRB or MTT assays.

Figure 2

Exponentially growing HCT116 BAX +/− and BAX −/− cells were exposed to increasing concentrations of 17-AAG for 96 hours and inhibition of cell proliferation was estimated using the (A) SRB assay or (B) MTT assay. Concentration-response curves were plotted and the GI50 value determined as the compound concentration required to inhibit cell proliferation by 50% compared to controls treated with drug vehicle. N=3, error bars indicate the mean ± SEM.